Jackson Research Group

The Jackson research group is interested in furthering our understanding of the pathogenesis and treatment of childhood asthma, with a focus on host-microbe interactions in both the inception and exacerbation of disease. The long-term goal is asthma prevention.

Dr. Jackson is the PI of clinical trials within the NHLBI-funded AsthmaNet [Step-Up Yellow Zone Inhaled Corticosteroids to Prevent Asthma Exacerbations (STICS)] and the NIAID-funded Inner City Asthma Consortium [Mechanisms Underlying Asthma Exacerbations Prevented and Persistent with Immune Based Therapy: A Systems Approach (MUPPITS)].

Dr. Jackson is leading additional studies aimed at identifying mechanisms by which viruses [rhinoviruses (RV-A, B and C) and enterovirus-D68] lead to wheezing and asthma exacerbations. These studies are examining the host response to infection and also interactions with the microbiome.

Lab News

Daniel Jackson, MD

Daniel J. Jackson, MD
Associate Professor